An in-depth look to WAVERLEY PHARMA INC operating, investing, and financing activities

WAVE free cash flow for Q2 24 is -250.32 k CAD. For 2023, WAVE free cash flow was -1.02 M CAD and operating cash flow was -1.02 M CAD.